Fund shareholders of CITIUS PHARMACEUTICALS INC
ISIN US17322U3068 · United States · LEI 5493005C10W36P4KQP40
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 223.3K $
- Share of capital
- 1.3 % of 27.5M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 167,738 | 101.4K $ | 0.00 % | 0.61 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 148,094 | 97K $ | 0.00 % | 0.54 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 26,359 | 17.3K $ | 0.10 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 11,655 | 7.6K $ | 0.04 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 353,846 | +18.2 % |
| 2026Q2 | 4 | -1 | 299,467 | +27.5 % |
| 2026Q1 | 5 | 0 | 234,916 | +44.0 % |
| 2025Q4 | 5 | +1 | 163,164 | +5.1 % |
| 2025Q3 | 4 | -5 | 155,232 | -51.9 % |
| 2025Q2 | 9 | +1 | 322,411 | -0.3 % |
| 2025Q1 | 8 | 323,354 |
Institutional managers
34 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 246,158 | 221.6K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 69,851 | 62.9K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 60,332 | 54 $ | as of Mar 31, 2026 |
| Asset Advisory Group, Inc. | 59,011 | 53.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 55,025 | 49.5K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 43,974 | 39.6K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 36,838 | 33.2K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 25,045 | 22.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 23,271 | 20.9K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 22,523 | 20.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 21,295 | 19.2K $ | as of Mar 31, 2026 |
| Arkadios Wealth Advisors | 20,000 | 18K $ | as of Mar 31, 2026 |
| Miller Financial Services LLC | 14,000 | 12.6K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 13,138 | 11.8K $ | as of Mar 31, 2026 |
| IFP Advisors, Inc | 7,083 | 6.4K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 6,519 | 5.9K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 5,228 | 4.7K $ | as of Mar 31, 2026 |
| CHELSEA COUNSEL CO | 4,626 | 3.6K $ | as of Mar 31, 2026 |
| Quent Capital, LLC | 4,265 | 3.8K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,785 | 2.5K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2,735 | 2.5K $ | as of Mar 31, 2026 |
| CURIO WEALTH, LLC | 2,000 | 1.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,364 | 1.2K $ | as of Mar 31, 2026 |
| Ameritas Advisory Services, LLC | 1,000 | 900 $ | as of Mar 31, 2026 |
| ASSETMARK, INC | 372 | 335 $ | as of Mar 31, 2026 |
Declared shareholders of CITIUS PHARMACEUTICALS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| CVI Investments, Inc. and 1 other | 9.90 % | 3,008,529 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of CITIUS PHARMACEUTICALS INC". https://titelia.com/en/stocks/citius-pharmaceuticals-inc-US17322U3068